Target (CBDY) Change in Accured Expenses (2013 - 2026)
Target (CBDY) reported Change in Accured Expenses of -$81254.0 for Q1 2026, down 5.67% year-over-year from -$86135.6 in Q1 2025, and down 109.64% quarter-over-quarter from $842908.0 in Q4 2025.
Target (CBDY) Change in Accured Expenses (2013 - 2026) Analysis & Trends
Target (CBDY) has 14 years of Change in Accured Expenses data on file, last reported at -$81254.0 in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at -$81254.0, down 5.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $601781.0 (up 285.92% YoY), and the FY2025 annual result was $606139.0, up 299.27% from the prior year.
- Change in Accured Expenses retreated to -$81254.0 in Q1 2026 per CBDY's latest filing, from $842908.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $1.2 million in Q4 2023 and troughed at -$1.6 million in Q2 2022.
- A 5-year average of $70132.6 and a median of -$76896.0 in 2025 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses tumbled 2550.51% in 2022, then soared 290.28% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at $435759.0 in 2022, then soared by 180.64% to $1.2 million in 2023, then sank by 67.88% to $392790.0 in 2024, then soared by 114.6% to $842908.0 in 2025, then slumped by 109.64% to -$81254.0 in 2026.
- Business Quant data shows CBDY's Change in Accured Expenses at -$81254.0 in Q1 2026, $842908.0 in Q4 2025, and -$311812.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 10.02 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 23.00 Mn |
| 10 | Target | - | - | 191,787.00 | -81,254.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -81,254.00 |
| Mar 31, 2026 | -81,254.00 |
| Dec 31, 2025 | 842,908.00 |
| Dec 31, 2025 | 842,908.00 |
| Sep 30, 2025 | -311,812.00 |
| Sep 30, 2025 | -311,812.00 |
| Jun 30, 2025 | 151,939.00 |
| Jun 30, 2025 | 151,939.00 |
| Mar 31, 2025 | -76,896.00 |
| Mar 31, 2025 | -76,896.00 |
| Dec 31, 2024 | 392,790.00 |
| Dec 31, 2024 | 392,790.00 |
| Sep 30, 2024 | -80,112.00 |
| Sep 30, 2024 | -80,112.00 |
| Jun 30, 2024 | -79,849.00 |
| Jun 30, 2024 | -79,849.00 |
| Mar 31, 2024 | -81,019.00 |
| Mar 31, 2024 | -81,019.00 |
| Dec 31, 2023 | 1.22 Mn |
| Dec 31, 2023 | 1.22 Mn |